First Tracks Biotherapeutics, Inc.(TRAX:US)
Market Cap$1.197B
Key Metrics
Price$34.46
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$248.47M
Total Assets$290.58M
Net Assets$257.46M
Total Debt$0
Key Metrics
Price$34.46
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$248.47M
Total Assets$290.58M
Net Assets$257.46M
Total Debt$0
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $0 | $0 |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $52.81M | $51.28M | |
| Research and Development | $33.96M | $41.47M |
| Selling, General, and Administrative | $18.86M | $9.82M |
| Other Operating Expenses | - | - |
Operating Income | -$52.81M | -$51.28M |
| $2.33M | $4.08M | |
| Non-Operating Interest Income | $2.33M | $4.09M |
| Non-Operating Interest Expense | - | - |
| Other Income/Expense | -$1K | -$7K |
Income Before Tax | -$50.48M | -$47.2M |
Income Tax | - | - |
Net Income | -$50.48M | -$47.2M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$50.48M | -$47.2M |
Shares Outstanding (Basic) | 34.75M | 34.75M |
Shares Outstanding (Diluted) | 34.75M | 34.75M |
EPS (Basic) | -$1.45 | -$1.36 |
EPS (Diluted) | -$1.45 | -$1.36 |
EBIT | -$52.81M | -$51.28M |
EBITDA | -$52.69M | -$50.67M |